Literature DB >> 28756405

The recognition and management of sepsis and septic shock: a guide for non-intensivists.

Alexander Keeley1, Paul Hine1, Emmanuel Nsutebu1.   

Abstract

Sepsis is common, often fatal and requires rapid interventions to improve outcomes. While the optimal management of sepsis in the intensive care setting is the focus of extensive research interest, the mainstay of the recognition and initial management of sepsis will occur outside the intensive care setting. Therefore, it is key that institutions and clinicians remain well informed of the current updates in sepsis management and continue to use them to deliver appropriate and timely interventions to enhance patient survival. This review discusses the latest updates in sepsis care including the new consensus definition of sepsis, the outcome of the proCESS, ProMISe and ARISE trials of early goal directed therapy (EGDT), and the most recent guidelines from the Surviving Sepsis Campaign. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  early goal directed therapy.; sepsis; septic shock; sequential (sepsis-related) organ failure assessment

Mesh:

Year:  2017        PMID: 28756405     DOI: 10.1136/postgradmedj-2016-134519

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  9 in total

1.  The management of septic shock and Ludwig's angina: A case report of a life-threatening condition.

Authors:  Endang Sjamsudin; Basaria Manurung; Asri Arumsari; Tantry Maulina
Journal:  SAGE Open Med Case Rep       Date:  2020-07-15

2.  qSOFA score for prediction of sepsis outcome in emergency department.

Authors:  Kavous Shahsavarinia; Payman Moharramzadeh; Reza Jamal Arvanagi; Ata Mahmoodpoor
Journal:  Pak J Med Sci       Date:  2020 May-Jun       Impact factor: 1.088

3.  Protective Effect of Zuojin Fang on Lung Injury Induced by Sepsis through Downregulating the JAK1/STAT3 Signaling Pathway.

Authors:  Jiangning Yin; Zhan Yu; Chuanyong Hou; Yigen Peng; Jianpeng Xiao; Jun Jiang
Journal:  Biomed Res Int       Date:  2021-01-06       Impact factor: 3.411

Review 4.  Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis.

Authors:  Muhammad Azfar Ruslan; Kamarul Aryffin Baharuddin; Norhayati Mohd Noor; Mohd Boniami Yazid; Abu Yazid Md Noh; Andey Rahman
Journal:  West J Emerg Med       Date:  2021-02-16

5.  Dracocephalum moldavica Ethanol Extract Suppresses LPS-Induced Inflammatory Responses through Inhibition of the JNK/ERK/NF-κB Signaling Pathway and IL-6 Production in RAW 264.7 Macrophages and in Endotoxic-Treated Mice.

Authors:  Kyeong-Min Kim; So-Yeon Kim; Tamanna Jahan Mony; Ho Jung Bae; Sang-Deok Han; Eun-Seok Lee; Seung-Hyuk Choi; Sun Hee Hong; Sang-Deok Lee; Se Jin Park
Journal:  Nutrients       Date:  2021-12-16       Impact factor: 5.717

6.  Antimicrobial Susceptibility Characteristics and Risk Factors Associated with Adult Sepsis in Wenzhou, China.

Authors:  Xiaoxiao Qu; Shishi Wang; Ying Qu; Huiyan Wang; Xuanmei Ye; Luming Tang; Qipeng Xie
Journal:  Infect Drug Resist       Date:  2022-03-08       Impact factor: 4.003

7.  Screening of potential key ferroptosis-related genes in sepsis.

Authors:  Shunan Cui; Kun Niu; Yining Xie; Shuo Li; Wenzhi Zhu; Ling Yu; Hongyu Tan
Journal:  PeerJ       Date:  2022-09-13       Impact factor: 3.061

8.  miR-133a-3p regulates the proliferation and apoptosis of intestinal epithelial cells by modulating the expression of TAGLN2.

Authors:  Xiaoxi Tian; Lihong Li; Guoqiang Fu; Jianyu Wang; Qianfeng He; Cuicui Zhang; Bingrui Qin; Jiahui Wang
Journal:  Exp Ther Med       Date:  2021-06-02       Impact factor: 2.447

9.  Positive Role of Delta Neutrophil Index (DNI) as a Prodiagnostic Marker in Cecal Ligation and Puncture (CLP)-Induced Sepsis Murine Model.

Authors:  Hyungdon Lee; Jae Min Lim; Jongwook Lee; Soo-Ki Kim; Taehun Lee
Journal:  Medicina (Kaunas)       Date:  2022-03-02       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.